tiprankstipranks
Advertisement
Advertisement
Intellia, Roku Trend with Analysts: What Investors Should Know
PremiumWeekend UpdatesIntellia, Roku Trend with Analysts: What Investors Should Know
1M ago
Analyst Maintains Buy on Intellia as Lonvo-z Progress and Strong Cash Runway Support Unchanged $49 Price Target
Premium
Ratings
Analyst Maintains Buy on Intellia as Lonvo-z Progress and Strong Cash Runway Support Unchanged $49 Price Target
1M ago
Intellia Therapeutics upgraded to Outperform from In Line at Evercore ISI
Premium
The Fly
Intellia Therapeutics upgraded to Outperform from In Line at Evercore ISI
1M ago
Intellia Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
PremiumThe FlyIntellia Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
2M ago
BlackBerry, Sony, Sunrun, Credo, Intellia: Insider Sell-Off Shock
Premium
Weekend Updates
BlackBerry, Sony, Sunrun, Credo, Intellia: Insider Sell-Off Shock
2M ago
Intellia Therapeutics price target raised to $17 from $12 at Wedbush
Premium
The Fly
Intellia Therapeutics price target raised to $17 from $12 at Wedbush
2M ago
Intellia Highlights Strong Phase 3 Lonvo-z HAE Results
PremiumCompany AnnouncementsIntellia Highlights Strong Phase 3 Lonvo-z HAE Results
3M ago
Intellia: Phase 3 HAELO Success Underpins Buy Rating as Analyst Maintains $25 Price Target
Premium
Ratings
Intellia: Phase 3 HAELO Success Underpins Buy Rating as Analyst Maintains $25 Price Target
3M ago
Intellia Therapeutics presents additional results from Phase 3 HAELO trial
Premium
The Fly
Intellia Therapeutics presents additional results from Phase 3 HAELO trial
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100